Nathalie Delzenne is Full Professor at the Université catholique de Louvain. She is a lecturer in Nutrition Biochemistry and Metabolism and is the leader of the Metabolism and Nutrition Research Group at the Louvain Drug Research Institute. She has been involved in international scientific committee (Editor for the current Opinion in Clinical Nutrition and Metabolism, member of the Scientific Board of the European Academy of Nutritional Science, former member of the Board of the Nutrition society (UK), vice-president of the Belgian Nutrition society, former member of the Board of directors of the International Scientific Association for Probiotics and Prebiotics). After a PhD in Pharmaceutical sciences obtained in 1991, and a post-doctoral certificate in Nutrition (Lausanne, CH), she performed a post-doctoral research in Paris (Inserm Unit 342) to analyze the effect of nutrients on gene expression in the field of obesity. Back at the Université catholique de Louvain, she started an academic carrier and has been involved in the experimental approach allowing to assess the functional effect of prebiotic-type nutrients, and in several international European Projects devoted to functional food. By working with prebiotics, her group has published more than 100 paper describing their effect on glucose/lipid metabolism, obesity-related disorder and inflammation.
Research Director at the French Research Institute in Agricultural Sciences, INRA, Dr. Joël Doré is currently President of the Executive Committee of the Pre-Industrial Demonstrator MetaGenoPolis, a platform of excellence dedicated to quantitative and functional metagenomics, funded by the French government Futures Investments. He is Deputy Head of the MICALIS institute “Food and Gut Microbiology for Human Health” and scientific board member of Microbiology Pole of the Doctoral School “Therapeutic Innovations” at Paris-XI University. Joël Doré received his PhD from the University of Illinois at Urbana-Champaign, USA, in 1988. His main research interest is the molecular assessment of the human intestinal microbiota in health and disease and metagenomic investigation of the molecular cross-talk between intestinal bacteria and human cells. Dr. Doré has published >120 publications in peer reviewed scientific journals. His goal is to provide a better understanding of the intestinal ecosystem in order to support therapeutic choices in the medical area, as well as health claims for functional foods.
Abdul Dulloo is Professor of Physiology in the Department of Medicine at the University of Fribourg, Switzerland. He obtained a Bachelor degree in Physiology and a PhD degree in Nutrition both from the University of London in UK, and a postdoctoral research fellowship at Harvard Medical School in Boston, USA. He subsequently worked as a research associate in Physiology at the University of Geneva, before joining in 1999 the University of Fribourg in Switzerland, where he has since been directing the Laboratory of Nutritional Energetics and Body Composition Regulation. His main research interests centre on elucidating the ‘thrifty’ mechanisms that interlink thermogenesis, body composition regulation and insulin resistance, and upon the search for bioactive food ingredients with thermogenic and insulin-sensitizing properties for managing obesity and diabetes. Dr Dulloo is currently an executive committee member of the Swiss Association for Study Obesity and an editorial board member of the International Journal of Obesity.
Harry Flint is leader of the Microbiology Group and of the Gut Health theme at the Rowett Institute of Nutrition and Health, University of Aberdeen, where he also holds a personal chair. He obtained his BSc and PhD in Genetics from the University of Edinburgh and subsequently held appointments at the Universities of Nottingham, the West Indies and Edinburgh. Over the past 27 years spent at the Rowett, Harry’s research has focussed on the impact of commensal and symbiotic micro-organisms in the mammalian gut on nutrition and health. Harry’s current research combines molecular approaches with cultural microbiology to uncover the roles of human colonic gut bacteria in fermentative metabolism and the degradation of dietary starch and plant cell wall polysaccharides. Harry is currently a member of the editorial boards of Environmental Microbiology, Gut Microbes and FEMS Microbiology Ecology.
Anna Krook's research is focused on unravelling regulatory sites in the signal transduction pathway/gene regulatory chain which regulates skeletal muscle insulin sensitivity and muscle metabolic profile. She completed her doctoral training at the University of Cambridge UK, focusing on naturally occurring mutations in the insulin receptor gene. Following Ph.D. training, she moved to the Department of Clinical Physiology at Karolinska Institutet, Stockholm to join Professor Harriet Wallberg-Henriksson’s group. At Karolinska Institutet she has studied insulin signalling in human skeletal muscle. She is currently professor at the Department of Phsyiology and Pharmacology at Karolinska Institutet. Current interests include muscle derived secreted factors as well as the role of miRNA in modulation of muscle metabolism.
Dr. Ruth Loos is Director of the Genetics of Obesity and Related Metabolic Traits Program at the Icahn School of Medicine at Mount Sinai. Her primary research interests focuses on the identification of genes and genetic loci contributing to the risk of obesity and related metabolic traits. She has been involved in gene-discovery since 2005, when ‘genome-wide association’ was introduced and has since actively contributed to many consortia that use this approach to identify genetic loci for a large number of metabolic traits. Increasingly, her gene-discovery work also focuses on the identification of low-frequency variants through the implementation exome-chip genotyping and sequencing projects, not only in individuals of white European descent, but also in those of African and Hispanic descent. Besides gene-discovery, Ruth uses epidemiological methods to follow-up on established loci with the aim to elucidate the pathways through which they increase risk of metabolic disease. Furthermore, her work also assesses the public health implications of the established loci by examining their predictive value and their interaction with lifestyle factors such as diet and physical activity.
Susanne Mandrup has been Professor at Department of Biochemistry and Molecular Biology, University of Southern Denmark since 2008. She obtained her PhD in Biochemistry from Odense University in 1992 and worked among others as a post doc in Prof. M. Daniel Lane’s group, Department of Biological Chemistry, Johns Hopkins University, Baltimore 1995-96. In 1996 and 1999 she was appointed Assistant Professor and Associate Professor, respectively, at Department of Molecular Biology, Odense University.
The research in the Mandrup group focuses on understanding the molecular cross-talk between transcriptional regulation and metabolism in adipocytes and pancreatic-cells, and in the transcriptional network regulating adipocyte differentiation. Susanne Mandrup recently received a Sapere Aude Advanced Grant from the Danish Independent Research Council and is one of the leading figures in the newly established Danish Diabetes Academy supported by the Novo Nordisk Foundation. Furthermore, she is part of the newly established Villum Center for Bioanalytical Sciences at University of Southern Denmark. She has participated in a large number of international research consortia and was 2005-2009 coordinator of the European FP6 project X-TRA-NET. She was member of the Danish Natural Science Research Council (2005 – 2010) and has since 2009 been member of The Medical and Natural Science Committee of the Novo Nordisk Foundation. In addition, she has served on several grant review panels under FP6 and FP7 and is currently member of the European Research Council starting grant panel for Genetics, Genomics, Bioinformatics and Systems Biology.
Fermín I. Milagro (Pamplona, Spain, 1970), graduated (PhD in Biology) in 1998 at the University of Navarra (Spain), is Full Professor in the Department of Nutrition, Food Science and Physiology at the University of Navarra. He has since published over 90 scientific articles, 120 congress communications and 8 book chapters. His current h-index is 17. He has wide experience in Nutrigenomics, Nutrigenetics and Epigenetics, with special emphasis in the nutrient–gene interaction in humans, animal and cellular models, always in relation with the development of obesity and related metabolic diseases. Some of his major research interests are inflammation, bioactive compounds, biomarkers and insulin signaling.
Max Nieuwdorp MD PhD is an internist Endocrinologist/ Associate Professor of Vascular Medicine and head of the Experimental Vascular Biology laboratory at the Academic Medical Center in Amsterdam, the Netherlands. After obtaining his PhD at University of Amsterdam followed by a postdoctoral fellowship at UC San Diego (prof Jeff Esko, Department of Cellular and Molecular Medicine), Dr Nieuwdorp started his own translational research group (currently 12 MD PhD students, 2 postdoctoral fellows) focusing on the causal role of (small) intestinal bacterial strains to treat insulin resistance, adipose tissue inflammation and cardiovascular disease.
Dr Susan Ozanne is a Reader in Developmental Endocrinology in the Institute of Metabolic Science Metabolic Research Laboratories at the University of Cambridge. She is also a Fellow of Churchill College, Cambridge, U.K. She obtained a first class honours degree in Biochemistry from the University of Edinburgh, Scotland in 1990. She then went to Christ’s College at the University of Cambridge where she obtained her PhD in 1994. Before being appointed to her current post she was a Diabetes U.K. R.D. Lawrence Fellow, a Wellcome Trust Career Development Fellow and a British Heart Foundation Lecturer. Her research interests are focused on understanding the mechanistic basis of the relationship between suboptimal early nutrition and growth and risk of diseases such as type 2 diabetes, obesity and cardiovascular disease in later life. Initially her work was directed towards understanding how under-nutrition during fetal life influenced long-term health but her research has now expanded to include studying the link between maternal over-nutrition and obesity on the long-term health of her offspring. Her research group works on animal models of early dietary manipulation as well as on biopsy material from low birth weight humans. Dr Ozanne is the author of over 100 peer-reviewed full papers on the early origins of health and disease and is an elected member of the council of the Society for the Developmental Origins of Health and Disease.